On the other hand, B cells have been implicated with MS since 1942, when increased levels of immunoglobulins (Igs) in the cerebrospinal fluid (CSF) of patients were first described to be suggestive of MS (Kabat et al., 1942). This evidence concerns the gene CUBN and myeloid sarcoma.